1. Home
  2. RBB vs IPSC Comparison

RBB vs IPSC Comparison

Compare RBB & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RBB Bancorp

RBB

RBB Bancorp

HOLD

Current Price

$23.85

Market Cap

363.0M

Sector

Finance

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.29

Market Cap

399.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBB
IPSC
Founded
2008
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
363.0M
399.0M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
RBB
IPSC
Price
$23.85
$2.29
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$22.00
$4.25
AVG Volume (30 Days)
60.7K
1.1M
Earning Date
04-20-2026
05-11-2026
Dividend Yield
2.68%
N/A
EPS Growth
24.49
91.30
EPS
1.83
N/A
Revenue
$5,167,000.00
$109,164,000.00
Revenue This Year
$20.50
N/A
Revenue Next Year
$6.90
N/A
P/E Ratio
$13.07
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$14.68
$0.44
52 Week High
$24.73
$2.97

Technical Indicators

Market Signals
Indicator
RBB
IPSC
Relative Strength Index (RSI) 62.46 49.59
Support Level $20.11 $1.87
Resistance Level $24.73 $2.67
Average True Range (ATR) 0.61 0.16
MACD 0.06 -0.02
Stochastic Oscillator 68.72 26.53

Price Performance

Historical Comparison
RBB
IPSC

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: